Quick Answer
Tevogen Bio Holdings Inc. reported Total Assets of $4.38 million for fiscal year 2025.
Tevogen Bio Holdings Inc. Total Assets — Annual History
| Fiscal Year | Total Assets | YoY Change |
|---|---|---|
| 2025 | $4.38M | +26.6% |
| 2024 | $3.46M | -37.1% |
| 2023 | $5.51M | -98.5% |
| 2022 | $357.14M | +1.2% |
| 2021 | $352.85M | — |
Quarterly Total Assets
| Quarter Ending | Total Assets | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $4.49M | +4.8% | +5.3% |
| June 30, 2025 | $4.27M | +29.0% | +4.8% |
| March 31, 2025 | $4.07M | +21.1% | +17.7% |
| December 31, 2024 | $3.46M | -37.1% | -19.3% |
| September 30, 2024 | $4.29M | -83.8% | +29.6% |
| June 30, 2024 | $3.31M | -87.4% | -1.6% |
| March 31, 2024 | $3.36M | -86.8% | -38.9% |
| December 31, 2023 | $5.51M | -98.5% | -79.2% |
- Tevogen Bio Holdings Inc. showed an increase of +26.6% in Total Assets compared to the prior fiscal year.
- Over the 2021–2025 period, Tevogen Bio Holdings Inc.’s total assets has declined by 98.8% (from $352.85 million to $4.38 million).
- The most recent figure is from Tevogen Bio Holdings Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 31, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: